Abbott Laboratories will pay over $384M after selling baby formula from taxpayer-funded programs in unsafe conditions, with Oregon receiving close to $1M from the settlement.

Markets are setting up for a rough open, with index futures softer, oil above $100 and rate hike odds high, yet the S&P 500 sits near record territory. Income investors watching dividends and capital preservation now face a real fork in the road. This article examines three large cap dividend payers exposed to these macro shocks and explains how today’s crosscurrents could affect their appeal. The handful of dividend stocks highlighted below are only a sample, while the full screen surfaced...

KSLM Radio - Reliable News Talk Radio serving Salem, Oregon and the Willamette Valley. Current, Credible, Consistent. Listen live at 1220 AM or 104.3 FM.

FILE PHOTO: Abbott Laboratories logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, U.S., October 18, 2021.

The case stems from a Cronobacter bacterial contamination at one of Abbott Laboratories

Abbott Laboratories will pay nearly $385 million dollars to settle federal allegations tied to powdered infant formula made at its Sturgis facility.The governme

Abbott (ABT) stock snaps losing streak after $385M DOJ baby formula recall settlement.